Iambic Therapeutics, Inc. (IAM) stock
IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$14.84−0.54 (-3.54%)
Close on Nov 12, 2026Market cap –P/E –Yield –
Statistics
No statistics for Iambic Therapeutics yet
Statistics are calculated from the financial statements Iambic Therapeutics files with the SEC and the daily share price.
See a number that looks wrong?